Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.
April 23, 2018 16:56 ET
|
Federman & Sherwood
OKLAHOMA CITY, April 23, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of...
Topin & Associates Has Been Selected by Myriad Genetics, Inc., to Market OnDose(R) Dose Optimization Technology
May 26, 2011 08:30 ET
|
Topin & Associates, Inc.
CHICAGO, May 26, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., has selected Topin & Associates (topin.com) to support the ongoing marketing of OnDose Dose Optimization Technology to the oncology...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myriad Pharmaceuticals, Inc. to Host Initial Public Conference Call On July 1, 2009
June 29, 2009 10:05 ET
|
Myrexis, Inc.
SALT LAKE CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRXV) today announced that it will hold a live webcast on Wednesday, July 1, 2009 at 10:00 AM EDT. Adrian...